FDA
-
-
-
-
-
-
-
FDA advisory panel votes to support GRAIL's multi-cancer detection test
-
-
-
-
-
-
-
Priority Health Collaborates With GRAIL as the First Michigan Health Plan to Offer the GalleriĀ® Multi-Cancer Early Detection Blood Test to Employer Plans
-
-
-
-
-
-
-
GRAIL Reports First Quarter 2026 Financial Results
-
-
-
-
-
-
-
Superpower partners with GRAIL to offer multi-cancer blood test
-
-
-
-
-
-
-
GRAIL Reports Fourth Quarter and Full Year 2025 Financial Results
-
-
-
-
-
-
-
Canaccord Genuity Reiterates Buy Rating on GRAIL, Inc. (GRAL)
-
-
-
-
-
-
-
Samsung units invest $110 million in GRAIL for Asia cancer test push
-
334,273 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


